The American Society of Anesthesiologists (ASA) put out a warning in June asking patients to stop taking GLP-1 drugs at least a week before elective surgeries due to an increased risk of the drugs causing vomiting during operation
The discussion also examines FDA-approved indications, dosing schedules, and known adverse-event profiles to clarify safety considerations
Each medication is also available under different brand names, which may influence dosages and patient responses
You might want to look into Restore Care offers a personalized approach to weight loss if you're looking for comprehensive support
However, if you have any serious side effects you should talk to your prescriber as soon as possible to discuss whether to lower your dose
Much of that work involves research into TRICARE's legislative and regulatory history, as a means to better understand the DHA's claim that TFL coverage of weight-loss medication is "inconsistent with existing statutory and regulatory authority." While the patchwork of statute and regulations involving TRICARE coverage of weight-loss treatments is complex, MOAA has not discovered any federal statute specifically excluding TFL beneficiaries from coverage of GLP-1 drugs or other treatments
